Evidence map›Paper›PMID 19597976›Full record

Trial reportCulture, medicine and psychiatry2009

"Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial.

Ted J Kaptchuk, Jessica Shaw, Catherine E Kerr, Lisa A Conboy, John M Kelley, Thomas J Csordas, Anthony J Lembo, Eric E Jacobson

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Culture, medicine and psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ted J KaptchukOsher Research Center, Harvard Medical School, 401 Park Drive, Boston, MA 02215, USA. ted_kaptchuk@hms.harvard.edu
Jessica Shaw
Catherine E Kerr
Lisa A Conboy
John M Kelley
Thomas J Csordas
Anthony J Lembo
Eric E Jacobson

Funding

ZINC STATUS AND T CELL DISORDER IN MILD HUMAN ZINC DEFICIENCYM01RR001032 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PASCUAL-LEONE, ALVARO · 1985 to 2008
$32.3M
Enhancing the Placebo Effect in Irritable Bowel SyndromeR01AT001414 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KAPTCHUK, TED · 2003 to 2006
$2.5M
Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · HARVARD MEDICAL SCHOOL · PI KAPTCHUK, TED · 2007 to 2016
$1.4M
Integrative Healing Model in IBS (RMI)R21AT002860 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KAPTCHUK, TED · 2004 to 2005
$254k
NCCIH NIH HHS 1K24 AT004095NCCIH NIH HHS 1R01 AT01414-01NCCIH NIH HHS 1R21 AT002860-01NCCIH NIH HHS K24 AT004095NCCIH NIH HHS R01 AT001414NCCIH NIH HHS R21 AT002860NCRR NIH HHS M01 RR001032NCRR NIH HHS RR 01032
6 · The paper itself

Abstract

Patients in the placebo arms of randomized controlled trials (RCT) often experience positive changes from baseline. While multiple theories concerning such "placebo effects" exist, peculiarly, none has been informed by actual interviews of patients undergoing placebo treatment. Here, we report on a qualitative study (n = 27) embedded within a RCT (n = 262) in patients with irritable bowel syndrome. Besides identical placebo acupuncture treatment in the RCT, the qualitative study patients also received an additional set of interviews at the beginning, midpoint, and end of the trial. Interviews of the 12 qualitative subjects who underwent and completed placebo treatment were transcribed. We found that patients (1) were persistently concerned with whether they were receiving placebo or genuine treatment; (2) almost never endorsed "expectation" of improvement but spoke of "hope" instead and frequently reported despair; (3) almost all reported improvement ranging from dramatic psychosocial changes to unambiguous, progressive symptom improvement to tentative impressions of benefit; and (4) often worried whether their improvement was due to normal fluctuations or placebo effects. The placebo treatment was a problematic perturbation that provided an opportunity to reconstruct the experiences of the fluctuations of their illness and how it disrupted their everyday life. Immersion in this RCT was a co-mingling of enactment, embodiment and interpretation involving ritual performance and evocative symbols, shifts in bodily sensations, symptoms, mood, daily life behaviors, and social interactions, all accompanied by self-scrutiny and re-appraisal. The placebo effect involved a spectrum of factors and any single theory of placebo--e.g. expectancy, hope, conditioning, anxiety reduction, report bias, symbolic work, narrative and embodiment--provides an inadequate model to explain its salubrious benefits.

Indexed as

Placebo EffectAcupuncture TherapyAdultAgedFemaleHumansInterviews as TopicIrritable Bowel SyndromeMaleMiddle AgedPatientsPhysician-Patient RelationsYoung Adult

Identifiers

PMID19597976
PMCPMC2716443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.